Pacific Biosciences of California, Inc. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
Pacific Biosciences of California, Inc. (PACB) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of -1.80% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-02-25
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was -1.80%.
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was -3.40%.
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was -1.80%.
- Pacific Biosciences of California, Inc. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2022 was -2.20%, a 120.18% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | -1.80% 10-K · filed 2026-02-25 | |
| 2024-12-31 | -3.40% 10-K · filed 2026-02-25 | -3.70% 10-K · filed 2025-03-17 |
| 2023-12-31 | -1.80% 10-K · filed 2026-02-25 | -2.10% 10-K · filed 2024-02-28 |
| 2022-12-31 | -2.20% 10-K · filed 2025-03-17 | |
| 2021-12-31 | 10.90% 10-K · filed 2024-02-28 | -10.90% 10-K · filed 2022-02-28 |
| 2020-12-31 | -15.20% 10-K · filed 2023-02-28 | 15.20% 10-K · filed 2021-02-26 |
| 2019-12-31 | 0.80% 10-K · filed 2022-02-28 | |
| 2018-12-31 | 1.60% 10-K · filed 2021-02-26 | |
| 2017-12-31 | 1.90% 10-K · filed 2020-02-28 | |
| 2016-12-31 | 1.60% 10-K · filed 2019-02-26 | |
| 2015-12-31 | 4.00% 10-K · filed 2018-02-26 | |
| 2014-12-31 | 1.30% 10-K · filed 2017-03-06 | -1.30% 10-K · filed 2015-03-12 |
| 2013-12-31 | 1.70% 10-K · filed 2016-03-11 | -1.70% 10-K · filed 2014-03-14 |
| 2012-12-31 | -1.70% 10-K · filed 2015-03-12 | |
| 2011-12-31 | -2.00% 10-K · filed 2014-03-14 | |
| 2010-12-31 | -1.60% 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |